1. Add-on imeglimin versus metformin dose escalation regarding glycemic control in patients with type 2 diabetes treated with a dipeptidyl peptidase-4 inhibitor plus low-dose metformin: study protocol for a multicenter, prospective, randomized, open-label, parallel-group comparison study (MEGMI study). Issue 6 (15th November 2022) Authors: Nomoto, Hiroshi; Takahashi, Akihiro; Nakamura, Akinobu; Kurihara, Hiroyoshi; Takeuchi, Jun; Nagai, So; Taneda, Shinji; Miya, Aika; Kameda, Hiraku; Cho, Kyu Yong; Miyoshi, Hideaki; Atsumi, Tatsuya Journal: BMJ open diabetes research and care Issue: Volume 10:Issue 6(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Beneficial effects of switching to denosumab from bisphosphonates or selective estrogen receptor modulators in postmenopausal women with type 2 diabetes and osteopenia/osteoporosis. Issue 7 (13th December 2020) Authors: Miyoshi, Arina; Kameda, Hiraku; Nagai, So; Nakamura, Akinobu; Miya, Aika; Takase, Takahiro; Atsumi, Tatsuya; Miyoshi, Hideaki Journal: Journal of diabetes investigation Issue: Volume 12:Issue 7(2021) Page Start: 1293 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Correlation between serum proinsulin levels and fatty liver: The Dynamics of Lifestyle and Neighborhood Community on Health Study Health Study. Issue 4 (1st March 2020) Authors: Miya, Aika; Nakamura, Akinobu; Miyoshi, Hideaki; Ukawa, Shigekazu; Nakamura, Koshi; Nakagawa, Takafumi; Terauchi, Yasuo; Tamakoshi, Akiko; Atsumi, Tatsuya Journal: Journal of diabetes investigation Issue: Volume 11:Issue 4(2020) Page Start: 964 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Correlation between serum proinsulin levels and fatty liver: The Dynamics of Lifestyle and Neighborhood Community on Health Study. Issue 4 (1st March 2020) Authors: Miya, Aika; Nakamura, Akinobu; Miyoshi, Hideaki; Ukawa, Shigekazu; Nakamura, Koshi; Nakagawa, Takafumi; Terauchi, Yasuo; Tamakoshi, Akiko; Atsumi, Tatsuya Journal: Journal of diabetes investigation Issue: Volume 11:Issue 4(2020) Page Start: 964 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Effect of switching from pioglitazone to the sodium glucose co‐transporter‐2 inhibitor dapagliflozin on body weight and metabolism‐related factors in patients with type 2 diabetes mellitus: An open‐label, prospective, randomized, parallel‐group comparison trial. Issue 3 (8th November 2018) Authors: Cho, Kyu Yong; Nakamura, Akinobu; Omori, Kazuno; Takase, Takahiro; Miya, Aika; Manda, Naoki; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, Hideaki Journal: Diabetes, obesity & metabolism Issue: Volume 21:Issue 3(2019) Page Start: 710 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Effects of pemafibrate on lipid metabolism in patients with type 2 diabetes and hypertriglyceridemia: A multi-center prospective observational study, the PARM-T2D study. (October 2022) Authors: Kito, Kenichi; Nomoto, Hiroshi; Sakuma, Ichiro; Nakamura, Akinobu; Cho, Kyu Yong; Kameda, Hiraku; Miya, Aika; Omori, Kazuno; Yanagiya, Shingo; Handa, Takahisa; Taneda, Shinji; Takeuchi, Jun; Nagai, So; Yamashita, Kumiko; Kurihara, Yoshio; Atsumi, Tatsuya; Miyoshi, Hideaki Journal: Diabetes research and clinical practice Issue: Volume 192(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Effects of switching from a dipeptidyl peptidase-4 inhibitor to oral semaglutide on glucose metabolism in patients with type 2 diabetes: protocol for a multicentre, prospective, randomised, open-label, parallel-group comparison study (the SWITCH-SEMA 2 study). Issue 5 (18th May 2022) Authors: Nomoto, Hiroshi; Furusawa, Sho; Nakamura, Akinobu; Takeuchi, Jun; Nagai, So; Yokoyama, Hiroki; Sakuma, Ichiro; Taneda, Shinji; Kurihara, Yoshio; Aoki, Shin; Miya, Aika; Kameda, Hiraku; Cho, Kyu Yong; Atsumi, Tatsuya; Miyoshi, Hideaki Journal: BMJ open Issue: Volume 12:Issue 5(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Favorable effect of sodium–glucose cotransporter 2 inhibitor, dapagliflozin, on non‐alcoholic fatty liver disease compared with pioglitazone. Issue 7 (2nd December 2020) Authors: Cho, Kyu Yong; Nakamura, Akinobu; Omori, Kazuno; Takase, Takahiro; Miya, Aika; Yamamoto, Kohei; Nomoto, Hiroshi; Kameda, Hiraku; Taneda, Shinji; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, Hideaki Journal: Journal of diabetes investigation Issue: Volume 12:Issue 7(2021) Page Start: 1272 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Impact of endogenous insulin secretion on the improvement of glucose variability in Japanese patients with type 2 diabetes treated with canagliflozin plus teneligliptin. Issue 8 (21st January 2021) Authors: Miya, Aika; Nakamura, Akinobu; Cho, Kyu Yong; Kawata, Shinichiro; Nomoto, Hiroshi; Nagai, So; Sugawara, Hajime; Taneda, Shinji; Tsuchida, Kazuhisa; Omori, Kazuno; Yokoyama, Hiroki; Takeuchi, Jun; Aoki, Shin; Kurihara, Yoshio; Atsumi, Tatsuya; Miyoshi, Hideaki Journal: Journal of diabetes investigation Issue: Volume 12:Issue 8(2021) Page Start: 1395 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Impaired insulin secretion predicting unstable glycemic variability and time below range in type 2 diabetes patients regardless of glycated hemoglobin or diabetes treatment. Issue 5 (9th November 2020) Authors: Miya, Aika; Nakamura, Akinobu; Handa, Takahisa; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Nagai, So; Miyoshi, Hideaki; Atsumi, Tatsuya Journal: Journal of diabetes investigation Issue: Volume 12:Issue 5(2021) Page Start: 738 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗